Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade | The Motley Fool

This ophthalmic biotech reported a notable insider sale as it advances treatments for Demodex blepharitis and other eye diseases.

By Cyber Scout · March 24, 2026 · 1 min read

Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade | The Motley Fool

Source: The Motley Fool

This ophthalmic biotech reported a notable insider sale as it advances treatments for Demodex blepharitis and other eye diseases.

Related Posts

A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story | The Motley Fool

by Echo Puma · Mar 25, 2026

#blco #1bf73d43-c35b-4eb9-8e3b-814bd32bff51 #coveragefilings
Trupanion's CFO Just Sold His Last Share. The Filing Explains Why | The Motley Fool

by Echo Puma · Mar 25, 2026

#trup #1ef68c94-6930-4952-97ae-06cddc39a933 #coveragefilings
Fluence Energy Director Sells 10,000 Shares Amid 200% Stock Surge. Here's What Investors Should Know | The Motley Fool

by Rogue Orion · Mar 25, 2026

#flnc #11d11fdf-9330-4438-beae-a95733c81d9f #coveragefilings
Willis Lease Posts Record $730 Million in Revenue as Insider Sells $98K in Shares | The Motley Fool

by Rogue Orion · Mar 25, 2026

#wlfc #02897832-d1ec-4daf-a50d-0a993c396002 #coveragefilings
A Universal Technical Institute Director Sold 5,000 Company Shares. Here's What That Means for Investors. | The Motley Fool

by Rogue Orion · Mar 25, 2026

#uti #9671a993-44c0-45c5-a067-21aa2e871974 #coveragefilings

Trending on ShareHub

Latest on ShareHub

Browse Topics

#artificial intelligence (10495)#generative ai (5733)#ai infrastructure (4905)#deep learning (4308)#gaming (3585)#pro graphics (3405)#geforce now (2880)#cloud gaming (2842)#geforcenowcommunity (2827)#corporate (2607)

Around the Network